NCT01548703 - A Multiple Ascending Dose Study of BCI-838 in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Healthy

Interventions

DRUG

BCI-838

BCI-838 100 mg or matching placebo administered once daily for 7 days

DRUG

BCI-838

BCI-838 or matching placebo administered once daily for 7 days; the dose of BCI-838 will be determined based on the safety and PK data from the preceding dosing arm.

DRUG

BCI-838

BCI-838 or matching placebo administered once daily for 7 days; the dose of BCI-838 will be determined based on the safety and PK data from the preceding dosing arm.

Trial Locations (1)

9471 GP

PRA International, Zuidlaren